CD40LG and COVID-19: A different approach based on chemiluminescence immunoassay (CLIA) and nano-LC coupled with a hybrid Q-Orbitrap was applied by Liang et al. [38] to analyze serum IgM and IgG in COVID-19 patients, categorized into four groups based on serological patterns.